Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |